Re-engineering of genetic circuit for 2-deoxystreptamine (2-DOS) biosynthesis in Escherichia coli BL21 (DE3)

Biotechnol Lett. 2013 Feb;35(2):285-93. doi: 10.1007/s10529-012-1077-2. Epub 2012 Oct 30.

Abstract

Various approaches for monocistronic constructions of genetic circuits have been designed for metabolite production but there has been no attempt to apply such methodology for aminoglycosides biosynthesis. Here, a simple and commercially available bio-part, despite the current trend focusing on the standardized BioBricks bio-parts available in the registry, is used. A 181-bp nucleotide fragment was designed for the efficient construction of an expression vector for monocistronic assembly of genes. Furthermore, a single vector with multi-monocistronic assembled genes for 2-deoxystreptamine (2-DOS) synthesis was constructed for production in engineered Escherichia coli. The working efficiency of model vector was concluded by reporter assay whereas the expressions of biosynthesis genes were confirmed by RT-PCR and SDS-PAGE. Production of 2-DOS was confirmed by TLC, LC-ELSD, and ESI-MS/MS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chromatography, Thin Layer
  • Electrophoresis, Polyacrylamide Gel
  • Escherichia coli / genetics*
  • Escherichia coli / metabolism*
  • Gene Expression
  • Genes, Reporter
  • Genetic Vectors
  • Hexosamines / biosynthesis
  • Mass Spectrometry
  • Metabolic Engineering*
  • Metabolic Networks and Pathways / genetics*
  • Real-Time Polymerase Chain Reaction

Substances

  • Hexosamines
  • 2-deoxystreptamine